PROPYLTHIOURACIL

Propylthiouracil inhibits thyroid peroxidase and peripheral T4toT3 conversion, reducing thyroid hormone synthesis. It is used in hyperthyroidism and pregnancyrelated thyrotoxicosis. Side effects include rash, agranulocytosis, hepatotoxicity, and arthralgia. Only GMP materials will be supplied, logistics all according to GDP.

SKU: dfa4ff8566a1 Category: Tag:

Product Description


Mechanism of Action

PROPYLTHIOURACIL demonstrates a highcomplexity biochemical interaction profile characterised by multilayer signalling integration, modular enzymatic pathway penetration, mitochondrial network modulation, ionflux recalibration, redoxstate equilibrium restructuring and transcriptionfactor axis reprogramming. Its molecular geometry enables conformational docking to catalytic pockets, allosteric domains, transmembrane receptor helices and cytoskeletal scaffolds, creating broad regulatory influence across metabolic, structural and genomic systems.

At the signalling level, PROPYLTHIOURACIL may modulate phosphorylation gradients, kinome cascade propagation (including MAPK, JNK, ERK, PI3KAKT, and AMPK axes), Gprotein subunit turnover, calcium wave propagation, secondary messenger amplification and stressadaptation thresholds. Mitochondrially, the compound can alter electrontransportchain efficiency, ATPADP cycling, mitochondrial ROS leakage, membrane potential polarity and respiratorycomplex activation ratios.

Advanced Research Value

PROPYLTHIOURACIL is particularly suited for:

  • Crosspathway interference mapping and kinome interaction grids
  • Ultrahigh resolution receptorligand docking and conformational prediction
  • Organellestress modelling (ER stress, mitochondrial folding stress, autophagic flux modulation)
  • Networklevel transcriptome rewiring using multiomics clustering
  • Precision cytoskeletalmechanics analysis including actin polymerisation and tubulin turnover
  • Apoptotic vs. survivalpathway bias quantification
  • Advanced SAR, QSAR and machinelearning molecularperformance modelling

Risks, Toxicodynamics & Cellular Hazard Spectrum

At elevated exposure levels, PROPYLTHIOURACIL may induce:

  • ROS surge and oxidative collapse
  • Mitochondrial hyperfragmentation or respiratorycomplex shutdown
  • Severe ionchannel destabilisation
  • Cytoskeletal disassembly and membrane-integrity breach
  • Aberrant transcriptionfactor activation, inflammatory bursts (NF-κB, STAT, IRF pathways)
  • Highgrade apoptosis, necroptosis or ferroptosis initiation
  • Epigenetic instability affecting methylation/acetylation balance

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C7H10N2OS

Molecular Weight

170.23 g/mol

CAS Number

51-52-5

Storage Condition

Commercially available propylthiouracil tablets should be stored in well-closed containers at a temperature less than 40 °C, preferably between 15-30 °C.

Solubility

less than 1 mg/mL at 68 °F (NTP, 1992)

Purity

Purity information is available upon request (COA).

Synonym

propylthiouracil; 51-52-5; 6-Propyl-2-thiouracil; Propacil; Prothyran

IUPAC/Chemical Name

6-propyl-2-sulfanylidene-1H-pyrimidin-4-one

InChl Key

KNAHARQHSZJURB-UHFFFAOYSA-N

InChl Code

InChI=1S/C7H10N2OS/c1-2-3-5-4-6(10)9-7(11)8-5/h4H,2-3H2,1H3,(H2,8,9,10,11)

References

https://pubchem.ncbi.nlm.nih.gov/compound/657298;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download